Dr. Orr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
96 Johnathan Lucas Street
Dept. of Gynecologic Oncology
Charleston, SC 29425Phone+1 843-792-9300Fax+1 843-792-7799
Education & Training
- University Of PittsburghMS, Clinical and Translational Science, 2020
- UPMC Medical EducationFellowship, Gynecologic Oncology, 2014 - 2017
- University of South Florida MorsaniResidency, Obstetrics and Gynecology, 2010 - 2014
- University of Tennessee Health Science Center College of MedicineClass of 2010
Certifications & Licensure
- SC State Medical License 2020 - 2025
- PA State Medical License 2014 - 2021
- FL State Medical License Active through 2010
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Kunschner Cup - Gynecologic Oncology Faculty Teaching Award University of Pittsburgh/UPMC, 2020
- CREOG Resident Education National Faculty Award American College of Obstetricians and Gynecologists, 2019
- Fellow Award of Excellence in Resident Gyn Education University of Pittsburgh, 2017
- Join now to see all
Clinical Trials
- Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer Start of enrollment: 2019 Jan 28
Publications & Presentations
PubMed
- 113 citationsPhase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancerJason Brown, Daniel K Chan, Jessica J. Shank, Kent A. Griffith, Huihui Fan
JCI Insight. 2020-06-04 - 147 citationsDiagnosis and Treatment of Ovarian Cancer.B.C. Orr, Robert P. Edwards
Hematology/oncology Clinics of North America. 2018-12-01 - 19 citationsPrevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.Christopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, Abigail Overacre-Delgoffe, Ashwin S Somasundaram
Science Translational Medicine. 2021-12-08
Abstracts/Posters
- Small cell neuroendocrine carcinoma of the cervix: does treatment sequence and type of hysterectomy improve outcomes?Orr BC, Lin JF, Beriwal S, Edwards RP, Kelley J L III, Olawaiye AB, Comerci JT, Huang M, Courtney-Brooks M, and Sukumvanich P., 2015 SGO Annual Meeting, Chicago, 2015
Press Mentions
- Dr. Orr on Ongoing Biomarker Research in Ovarian CancerJanuary 27th, 2020
- Recurrent Ovarian Cancer: Combination Therapies and New Clinical TrialsAugust 18th, 2020
Committees
- Committee Member, NRG Ovarian Cancer Subcommittee 2023 - Present
- Committee Member, NRG Developmental Therapeutics Committee 2023 - Present
- Committee Member, NRG Immunotherapy Subcommittee 2023 - Present
- Committee Member, NRG Surgical Oncology 2018 - Present
- Fellow Representative, SGO Educational Committee 2014 - 2017
Professional Memberships
- Member
- Member
- Society of Gynecologic OncologyMember
- Member
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: